Dominant negative murine serum response factor: Alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets

Molecular and Cellular Biology

Volumn 19, Issue 7, 1999, Pages 4582-4591

  Belaguli, Narasimhaswamy S ^a   Zhou, Wei ^a   Trinh, Thuy Hanh T ^a   Majesky, Mark W ^a   Schwartz, Robert J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; TRANSACTIVATION;

ANIMALIA; MURINAE; RODENTIA;

EID: 0033000331     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.7.4582     Document Type: Article

References (64)

1. Annweiler, A., M. Muller-Immergluck, and T. Wirth. 1992. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol. Cell. Biol. 12:3107-3116.
2. Arsenian, S., B. Weinhold, M. Oelgeschlager, U. Ruther, and A. Nordheim. 1998. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17:6289-6299.
3. Belaguli, N. S., L. A. Schildmeyer, and R. J. Schwarte. 1997. Organization and myogenic restricted expression of the murine serum response factor gene. J. Biol. Chem. 272:18222-18231.
4. Belaguli, N. S., J. L. Sepulveda, V. Nigam, and R. J. Schwartz. Unpublished data.
5. Bickmore, W. A., K. Oghene, M. H. Little, A. Seawright, V. VanHeyningen, and N. D. Hastie. 1992. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science 257:235-238.
6. Chen, C.-Y., and R. J. Schwartz. 1996. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac α-actin gene transcription. Mol. Cell. Biol. 16:6372-6384.
7. Croissant, J. D., J. H. Kim, G. Eichele, L. Goering, J. Lough, R Prywes, and R. J. Schwartz. 1996. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. Dev. Biol. 177:250-264.
8. Das, G., and W. Herr. 1993. Enhanced activation of the human histone H2B promoter by an Oct-1 variant generated by alternative splicing. J. Biol. Chem. 268:25026-25032.
9. Epstein, J. A., T. Glaser, J. Cai, L. Jepeal, D. S. Walton, and R. L. Mass. 1994. Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing. Genes Dev. 8:2022-2034.
10. Ernst, W. H., R. Janknecht, M. A. Cahill, and A. Nordheim. 1995. Transcriptional repression mediated by the serum response factor. FEBS Lett. 357:45-49.
11. Foulkes, N. S., and F. Sassone-Corsi. 1992. More is better: activators and repressors from the same gene. Cell 68:411-414.
12. Foulkes, N. S., B. Mellstrom, E. Benusigllo, and P. Sassone-Corsi. 1992. Developmental switch of CREM function during spermatogenesis: from antagonist to activator. Nature 355:80-84.
13. SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 6:2066-2076.
14. Gadson, P. F., Jr., C. Rossignol, J. McCoy, and T. H. Rosenquist. 1993. Expression of elastin, smooth muscle alpha-actin, and c-jun as a function of the embryonic lineage of vascular smooth muscle cells. In Vitro Cell Dev. Biol. Anim. 29A:773-781.
15. Gauthier-Rouviere, C., Q. Q. Cai, N. Lautredou, A. Fernanda, J. M. Blanchard, and N. J. Lamb. 1993. Expression and purification of the DNA-binding domain of SRF: SRF-DM, a part of a DNA-binding protein which can act as a dominant negative mutant in vivo. Exp. Cell Res. 299:208-215.
16. Gauthier-Rouviere, C., M. Vandromme, D. Tuil, N. Lautredou, M. Morris, M. Soulez, A. Kahn, A. Fernandez, and N. J. Lamb. 1996. Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol. Biol. Cell 7:719-729.
17. Gius, D., X. M. Cao, F. J. Rauscher, D. R. Cohen, T. Curran, and V. P. Sukhatme. 1990. Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements. Mol. Cell. Biol. 10:4243-4255.
18. Groisman, R., H. Masutani, M.-P. Leibovitch, P. Robin, I. Soudant, D. Trouche, and A. Harel-Bellan. 1996. Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix proteins. J. Biol. Chem. 271:5258-5264.
19. Han, T.-H., and R. Prywes. 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:2907-2915.
20. Herrera, R. E., P. E. Shaw, and A. Nordheim. 1989. Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 340:68-70.
21. Hewitt, S. M., G. C. Fraizer, Y.-J. Wu, F. J. Rauscher III, and G. F. Saunders. 1996. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation. J. Biol. Chem. 271:8588-8592.
22. Johansen, F.-E., and R. Prywes. 1993. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Mol. Cell. Biol. 18:4640-4647.
23. Jollot, V., M. Demma, and R. Prywes. 1995. Interaction with RAP74 subunit of TFIIF is required for transcriptional activation by serum response factor. Nature 373:632-635.
24. Kozmik, Z., R. Kurzbauer, P. Dorfler, and M. Busslinger. 1993. Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties. Mol. Cell. Biol. 13:6024-6035.
25. Landerholm, T. E., X. R. Dong, J. Lu, N. S. Belaguli, R. J. Schwartz, and M. Majesky. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cell. Development 126:2053-2062.
26. Lee, T.-C., V. Shi, and R. J. Schwartz. 1992. Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal alpha-actin transcription in embryonic myoblasts. Proc. Natl. Acad. Sci. USA 89:9814-9818.
27. Leifer, D., D. Krainc, Y.-T. Yu, J. McDennott, R. E. Breitbart, J. Heng, R. L. Neve, B. Kosofsky, B. Nadal-Ginard, and B. Lipton. 1992. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl. Acad. Sci. USA 90:1546-1550.
28. Li, L., Z.-C. Liu, B. Mercer, P. Overtook, and E. N. Olson. 1997. Evidence for serum response factor-mediated regulatory networks governing SM22α transcription in smooth, skeletal, and cardiac muscle cells. Dev. Biol. 187: 311-321.
29. Lillycrop, K. A., and D. S. Latchman. 1992. Alternative splicing of the Oct-2 transcription factor is differentially regulated in B cells and neuronal cells and results in protein isoforms with opposite effects on the activity of octamer/TAATGARAT-containing promoters. J. Biol. Chem. 267:24960-24966.
30. Liu, S. H., J. T. Ma, A. Y. Yueh, S. P. Lees-Miller, C. W. Anderson, and S. Y. Ng. 1993. The carboxyl-terminal transactivation domain of human serum response factor contains DNA-activated protein kinase phosphorylation sites. J. Biol. Chem. 268:21147-21154.
31. Lopez, J. A. 1995. Developmental role of transcription factor isoforms generated by alternative splicing. Dev. Biol. 172:396-411.
32. Macneil, C., B. Ayres, A. C. Laverriere, and J. E. Burch. 1997. Transcripts for functionally distinct isoforms of chicken GATA-5 are differentially expressed from alternative first exons. J. Biol. Chem. 272:8396-8401.
33. Martin, J. F., J. J. Schwarz, and E. N. Olson. 1993. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. USA 90:5282-5286.
34. Martin, J. F., J. M. Miano, C. M. Hustad, N. G. Copeland, N. A. Jenkins, and E. N. Olson. 1994. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647-1656.
35. McDermott, J. C., M. C. Cordoso, Y.-T. Yu, V. Andres, D. Leifer, D. Krainc, S. A. Lipton, and B. Nadal-Ginard. 1993. HMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol. 13:2564-2577.
36. Mohun, T. J., A. E. Chambers, N. Towers, and M. V. Taylor. 1991. Expression of genes encoding the transcription factor SRF during early development of Xenopus laevis: identification of a CArG box-binding activity as SRF. EMBO J. 10:933-940.
37. Morris, A. E., B. Kloss, R. E. McChesney, C. Bancroft, and L. A. Chasin. 1992. An alternatively spliced Pit-1 isoform altered in its ability to transactivate. Nucleic Acids Res. 20:1355-1361.
38. Morris, P. J., T. Theil, C. J. A. Ring, K. A. Lillycrop, T. Moroy, and D. S. Latchman. 1994. The opposite and antagonistic effects of the closely related POU family transcription factors on the activity of a target promoter are dependent upon differences in the POU domain. Mol. Cell. Biol. 14:6907-6914.
39. Nornes, S., I. Mikkola, S. Krauss, M. Delghandi, M. Perander, and T. Johansen. 1996. Zebrafish Pax9 encodes two proteins with distinct C-terminal transactivating domains of different potency negatively regulated by adjacent N-terminal sequences. J. Biol. Chem. 271:26914-26923.
40. Olson, E. N., M. Perry, and R. A. Schulz. 1995. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. Biol. 172:2-14.
41. Ornatsky, O. I., J. J. Andreucci, and J. C. McDermott. 1997. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272:33271-33278.
42. Owens, G. K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
43. Pellegrini, L., S. Tans, and T. J. Richmond. 1995. Structure of serum response factor core bound to DNA. Nature 376:490-498.
44. Pollock, R., and R. Treisman. 1991. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5:2327-2341.
45. Reecy, J., N. S. Belaguli, and R. J. Schwartz. 1998. SRF/homeobox protein interactions, p. 273-290. In R. Harvey and N. Rosenthal (ed.), Heart development. Academic Press, San Diego, Calif.
46. Reichmann, J. L., and E. M. Meyerowitz. 1997. MADS domain proteins in plant development J. Biol. Chem. 378:1079-1101.
47. Rivera, V. M., C. K. Miranti, R. P. Misra, D. D. Ginty, R.-H. Chen, J. Blenis, and M. E. Greenberg. 1993. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol. Cell. Biol. 13:6260-6273.
48. Ross, R. 1993. Atherosclerosis: a defence mechanism gone awry. Am. J. Pathol. 143:987-1002.
49. Ruzicka, D. L., and R. J. Schwartz. 1988. Sequential activation of alpha-actin genes during avian cardiogenesis: vascular smooth muscle alpha-actin gene transcripts mark the onset of cardiomyocyte differentiation. J. Cell Biol. 107:2575-2586.
50. Sartorelli, V., K. Webster, and L. Kedes. 1990. Muscle-specific expression of the cardiac α-actin gene requires MyoD1, CArG-box binding factor, and SP1. Genes Dev. 4:1811-1822.
51. Schwarz-Sommer, Z., P. Huijser, W. Nacken, H. Seadler, and H. Sommer. 1990. Genetic control of flower development by homeotic genes in Antirrhinum majus. Science 250:931-936.
52. Shore, P., and A. D. Sharrocks. 1995. The MADS-box family of transcription factors. Eur. J. Biochem. 229:1-13.
53. Soulez, M., C. Gauthier-Rouviere, P. Chafey, D. Hentzen, M. Vandromme, N. Lautredou, N. Lamb, N. Kahn, and D. Tuil. 1996. Growth and differentiation of C2 myogenic cells are dependent on serum response factor. Mol. Cell. Biol. 16:6065-6074.
54. Spencer, J. A., and R. P. Misra. 1996. Expression of the serum response factor gene is regulated by serum response factor binding sites. J. Biol. Chem. 271:16535-16543.
55. Suzuki, E., K. M. Guo, M. Kolman, Y.-T. Yu, and K. Walsh. 1995. Serum induction of MEF2/RSRF in vascular myocytes is mediated at the level of translation. Mol. Cell. Biol. 15:3415-3423.
56. Tanaka, T., K. Tanaka, S. Ogawa, M. Kurokawa, K. Mitani, J. Nishida, Y. Shibata, Y. Yazaki, and H. Hirai. 1995. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternatively spliced forms. EMBO J. 14:341-350.
57. Topouzis, S., and M. Majesky. 1996. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev. Biol. 178:430-445.
58. Treisman, R. 1995. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14:4905-4913.
59. Tsukamoto, K., Y. Nakamura, and N. Niikawa. 1994. Isolation of two isoforms of the PAX3 gene transcripts and their tissue-specific alternative expression in human adult tissues. Hum. Genet. 93:270-274.
60. Vandromme, M., C. Gauthier-Rouviere, G. Carnac, N. Lamb, and A. Fernandez. 1992. Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J. Cell Biol. 118:1489-1500.
61. Yin, J. C. P., J. S. Wallach, E. L. Wilder, J. Klingensmith, D. Dang, N. Perrimon, H. Zhou, T. Tully, and W. G. Quinn. 1995. A Drosophila CREB/CREM homolog encodes multiple isoforms, including a cyclic AMP-dependent protein kinase-responsive transcriptional activator and antagonist. Mol. Cell. Biol. 15:5123-5130.
62. Yu, Y.-T., R. E. Breitbart, L. B. Smoot, Y. Lee, V. Mahdavi, and B. Nadal-Ginard. 1992. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6:1783-1798.
63. Zhu, H., A. L. Roy, R. G. Roeder, and R. Prywes. 1991. Serum response factor affects preinitiation complex formation by TFIID in vitro. New Biol. 3:455-464.
64. Zhu, C., F.-E. Johansen, and R. Prywes. 1997. Interaction of ATF6 and serum response factor. Mol. Cell. Biol. 17:4957-4966.